Epigenetic Modulation Is a Key Mechanism in Cognitive Deficit: Unveiling Garcinol as a Potent HAT Inhibitor in Improving Alzheimer’s Disease

Read full text
Authors: Abhishek Mishra, Bhabani Sankar Satapathy, Pratap Kumar Sahu, Aruna Ghose, Sudhir Kumar Paidesetty
Cited by: 1
References: 193

Abstract

, possesses potent HAT inhibitory effect. Reports show that GL exhibits profound antioxidant, anti-inflammatory, anticancer, and neuroprotection effects. Neuroprotection of GL could be attributed to its ability to reduce oxidative stress and modulate important signaling pathways involved in neuronal degeneration. Present review unveils potentiality of HAT inhibitors in improving memory functions and neuroprotection; with a special focus on GL. Mechanical insights into activity of GL in ameliorating neurodegeneration have been discussed with rationalized evidence of various preclinical reports. Side by side, a portion has been devoted to update the trending drug delivery approaches investigated in recent times for GL toward improved pharmacological performance.

Fields of Study & Subjects

Natural Compound Pharmacology Studies Autophagy in Disease and Therapy Alzheimer's disease research and treatments

Publication details

Journal / source
ACS Omega
Publisher
American Chemical Society (ACS)
Volume
11
Issue
18
Pages
26129–26150
Publication date
1 May 2026
Language
EN